Formulation and Evaluation of Lercanidipine HCL Loaded Nanomicelles

Authors

  • Hala Mohammed Fatih Ministry of Health , Department of Pharmaceutics, Kirkuk general Hospital, Kirkuk, Iraq.
  • Kawther Khalid Ahmed Department of Pharmaceutics, College of Pharmacy, University of Baghdad, Baghdad, Iraq.

DOI:

https://doi.org/10.31351/vol35iss1pp80-88

Keywords:

Encapsulation Efficiency (EE%) , thin-film hydration , lercandipine HCl, nanomicelle, soluplus

Abstract

Among the strong calcium channel blockers, lercanidipine hydrochloride (LER) has been shown to be useful in reducing blood pressure by acting on L-type calcium channels. Nevertheless, the main drawback of lercanidipine is that it is a BCS class II medication with poor solubility and a 10% oral bioavailability because of significant first pass metabolism. The goal of this study is to use the thin film hydration process to generate and assess lercanidipine nanomicelles utilizing soluplus in conjugation with other surfactants/polymers at different ratios in order to boost the solubility of virtually insoluble LER. Six formulations were prepared and analyzed for their micelles size, polydispersity index (PDI), encapsulation efficiency (EE%), and in-vitro release. The optimum formula was determined to be the one prepared using soluplus, poloxamer188 and tween80(50mg). Micelle size was found to be 62.26 nm, with PDI 0.233 and EE (88.8%). An in-vitro release study was conducted, and the results showed that the chosen formula (solu/p188/tween50) released the entire dose of drug in 75 minutes with 94% release, compared to only 53% for pure drug.These findings indicate the strong potential of employing LER HCl micelles in dosage form formulation.

How to Cite

1.
Hala Mohammed Fatih, Ahmed KK. Formulation and Evaluation of Lercanidipine HCL Loaded Nanomicelles. Iraqi Journal of Pharmaceutical Sciences [Internet]. 2026 Mar. 28 [cited 2026 Mar. 31];35(1):80-8. Available from: https://bijps.uobaghdad.edu.iq/index.php/bijps/article/view/3930

Publication Dates

Received

2024-06-24

Revised

2024-10-04

Accepted

2025-02-05

Published Online First

2026-03-29

References

Hamed SB, Abd Alhammid SN. Formulation and characterization of felodipine as an oral nanoemulsions. Iraqi J Pharm Sci (P-ISSN 1683-3597 E-ISSN 2521-3512). 2021;30(1):209–17.

Dahash RA, Rajab NA. Formulation and Investigation of Lacidipine as a Nanoemulsions. Iraqi J Pharm Sci (P-ISSN 1683-3597 E-ISSN 2521-3512). 2020;29(1):41–54.

Alhagiesa AW, Ghareeb MM. The Formulation and Characterization of Nimodipine Nanoparticles for the Enhancement of solubility and dissolution rate. Iraqi J Pharm Sci (P-ISSN 1683-3597 E-ISSN 2521-3512). 2021;30(2):143–52.

Al-Hassani HR, Al-Khedairy EBH. Formulation and In-Vitro Evaluation of Meloxicam Solid Dispersion using Natural Polymers. Iraqi J Pharm Sci (P-ISSN 1683-3597 E-ISSN 2521-3512). 2021;30(1):169–78.

Alwan RM, Rajab NA. Nanosuspensions of selexipag: formulation, characterization, and in vitro evaluation. Iraqi J Pharm Sci (P-ISSN 1683-3597 E-ISSN 2521-3512). 2021;30(1):144–53.

Alves VM, Hwang D, Muratov E, Sokolsky-Papkov M, Varlamova E, Vinod N, et al. Cheminformatics-driven discovery of polymeric micelle formulations for poorly soluble drugs. Sci Adv. 2019;5(6):eaav9784.

Gong J, Chen M, Zheng Y, Wang S, Wang Y. Polymeric micelles drug delivery system in oncology. J Control Release. 2012;159(3):312–23.

Li Y, Zhang T, Liu Q, He J. PEG-derivatized dual-functional nanomicelles for improved cancer therapy. Front Pharmacol. 2019;10:808.

Yu G, Ning Q, Mo Z, Tang S. Intelligent polymeric micelles for multidrug co-delivery and cancer therapy. Artif cells, nanomedicine, Biotechnol. 2019;47(1):1476–87.

Baccile N, Poirier A, Seyrig C, Le Griel P, Perez J, Hermida-Merino D, et al. Chameleonic amphiphile: The unique multiple self-assembly properties of a natural glycolipid in excess of water. J Colloid Interface Sci. 2023;630:404–15.

Trinh HM, Joseph M, Cholkar K, Mitra R, Mitra AK. Nanomicelles in diagnosis and drug delivery. In: Emerging nanotechnologies for diagnostics, drug delivery and medical devices. Elsevier; 2017. p. 45–58.

Vadlapudi AD, Mitra AK. Nanomicelles: an emerging platform for drug delivery to the eye. Ther Deliv. 2013;4(1):1–3.

Mallya P, DV G, Mahendran B, Bhavya M V, Jain V. INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACEUTICAL SCIENCES. 2020;

Lüscher TF, Cosentino F. The classification of calcium antagonists and their selection in the treatment of hypertension: a reappraisal. Drugs. 1998;55(4):509–17.

Bang LM, Chapman TM, Goa KL. Lercanidipine: a review of its efficacy in the management of hypertension. Drugs. 2003;63:2449–72.

Shaikh F, Patel V, Patel M, Surt N. Dissolution method development and validation for lercanidipine hydrochloride tablets. Dissolution Technol. 2018;25(1):38–46.

Barchielli M, Dolfini E, Farina P, Leoni B, Targa G, Vinaccia V, et al. Clinical pharmacokinetics of lercanidipine. J Cardiovasc Pharmacol. 1997;29:S1–15.

McClellan KJ, Jarvis B. Lercanidipine: a review of its use in hypertension. Drugs. 2000;60:1123–40.

Pandey S, Chandekar E, Wattamwar A, Pandit S, Joshee H, Patil A. Enhancement of wettability and in vitro dissolution properties of lercanidipine hydrochloride by solid dispersion technique. Thai J Pharm Sci. 2012;36(3).

Butani SB. Preparation and evaluation of self-micro emulsifying drug delivery systems of Lercanidipine HCL using medium and short chain glycerides: A comparative study. Asian J Pharm. 2016;10(04).

Menezes A, Lysetty S, Naha A. Formulation of polymeric nanoparticles of lercanidipine by two bottom down techniques optimized by design of experiment. Mater Plast. 2020;57(3):1–18.

Linn M, Collnot EM, Djuric D, Hempel K, Fabian E, Kolter K, et al. Soluplus® as an effective absorption enhancer of poorly soluble drugs in vitro and in vivo. Eur J Pharm Sci. 2012;45(3):336–43.

Yassin AEB, Massadeh S, Alshwaimi AA, Kittaneh RH, Omer ME, Ahmad D, et al. Tween 80-Based Self-Assembled Mixed Micelles Boost Valsartan Transdermal Delivery. Pharmaceuticals. 2023;17(1):19.

Guo Y, Luo J, Tan S, Otieno BO, Zhang Z. The applications of Vitamin E TPGS in drug delivery. Eur J Pharm Sci. 2013;49(2):175–86.

Albassam NY, Kassab HJ. Diacerein loaded novasome for transdermal delivery: Prepartion, in-vitro characterization and factors affecting formulation. Iraqi J Pharm Sci (P-ISSN 1683-3597 E-ISSN 2521-3512). 2023;32(Suppl.):214–24.

Abdulqader AA, Rajab NA. Bioavailability study of Posaconazole in rats after oral Poloxamer P188 Nano-micelles and oral Posaconazole pure drug. J Adv Pharm Educ Res Apr–Jun. 2023;13(2):141.

Ojha T, Hu Q, Colombo C, Wit J, van Geijn M, van Steenbergen MJ, et al. Lyophilization stabilizes clinical‐stage core‐crosslinked polymeric micelles to overcome cold chain supply challenges. Biotechnol J. 2021;16(6):2000212.

Shaikh FI, Patel VB. Enhancement of dissolution of Lercanidipine hydrochloride using solid dispersion technique. Res J Recent Sci. 2015;2277:2502.

Abdulqader AAE, Sultan NAR. Preparation and characterization of posaconazole as a nano-micelle using d-α-tocopheryl polyethylene glycol 1000 succinate (TPGS). Iraqi J Pharm Sci. 2023;32:26–32.

Rashid AM, Abd-Alhammid SN. Formulation and characterization of itraconazole as nanosuspension dosage form for enhancement of solubility. Iraqi J Pharm Sci. 2019;28(2):124–33.

Ghareeb MM. Formulation and characterization of isradipine as oral nanoemulsion. Iraqi J Pharm Sci (P-ISSN 1683-3597 E-ISSN 2521-3512). 2020;29(1):143–53.

Al-Dulaimi AF, Al-kotaji M, Abachi FT. Development of Novel Paracetamol/Naproxen co-crystals for Improvement in Naproxen Solubility. Iraqi J Pharm Sci (P-ISSN 1683-3597 E-ISSN 2521-3512). 2022;31(1):202–19.

Ghadhban HY, Ahmed KK. Nanosuspension-Based Repaglinide Fast-Dissolving Buccal Film for Dissolution Enhancement. AAPS PharmSciTech. 2024;25(6):161.

Shen J, Burgess DJ. In vitro dissolution testing strategies for nanoparticulate drug delivery systems: recent developments and challenges. Drug Deliv Transl Res. 2013;3:409–15.

Shaikh F, Patel V, Patel M, Surt N. Dissolution method development and validation for lercanidipine hydrochloride tablets. Dissolution Technol. 2018;25(1):38–46.

Pignatello R, Corsaro R, Bonaccorso A, Zingale E, Carbone C, Musumeci T. Soluplus® polymeric nanomicelles improve solubility of BCS-class II drugs. Drug Deliv Transl Res. 2022;12(8):1991–2006.

Wei X, Gong C, Shi S, Fu S, Men K, Zeng S, et al. Self-assembled honokiol-loaded micelles based on poly (ɛ-caprolactone)-poly (ethylene glycol)-poly (ɛ-caprolactone) copolymer. Int J Pharm. 2009;369(1–2):170–5.

Zhu S, Hong M, Liu C, Pei Y. Application of Box-Behnken design in understanding the quality of genistein self-nanoemulsified drug delivery systems and optimizing its formulation. Pharm Dev Technol. 2009;14(6):642–9.

Hekmat A, Attar H, Seyf Kordi AA, Iman M, Jaafari MR. New oral formulation and in vitro evaluation of docetaxel-loaded nanomicelles. Molecules. 2016;21(9):1265.

Salimi A, Zadeh BSM, Kazemi M. Preparation and optimization of polymeric micelles as an oral drug delivery system for deferoxamine mesylate: in vitro: and: ex vivo: studies. Res Pharm Sci. 2019;14(4):293–307.

Dong K, Zhang M, Liu Y, Gao X, Wu X, Shi D, et al. Pterostilbene-loaded Soluplus/Poloxamer 188 mixed micelles for protection against acetaminophen-induced acute liver injury. Mol Pharm. 2023;20(2):1189–201.

Tanida S, Kurokawa T, Sato H, Kadota K, Tozuka Y. Evaluation of the micellization mechanism of an amphipathic graft copolymer with enhanced solubility of ipriflavone. Chem Pharm Bull. 2016;64(1):68–72.

Alopaeus JF, Hagesæther E, Tho I. Micellisation mechanism and behaviour of Soluplus®–furosemide micelles: Preformulation studies of an oral nanocarrier-based system. Pharmaceuticals. 2019;12(1):15.

Knoch H, Ulbrich MH, Mittag JJ, Buske J, Garidel P, Heerklotz H. Complex micellization behavior of the polysorbates Tween 20 and Tween 80. Mol Pharm. 2021;18(8):3147–57.

Downloads

Published

2026-03-28

Most read articles by the same author(s)